Betacetylmethadol
 | |
| Systematic (IUPAC) name | |
|---|---|
| (3S,6R)-6-(dimethylamino)-4,4-diphenyl-3-heptanyl acetate | |
| Clinical data | |
| |
| Identifiers | |
| 17199-59-6 | |
| None | |
| PubChem | CID 62710 |
| DrugBank | DB01522 |
| ChemSpider | 56457 |
| ChEMBL | CHEMBL2105619 |
| Chemical data | |
| Formula | C23H31NO2 |
| 353.498 g/mol | |
|
SMILES
| |
| |
Betacetylmethadol is a synthetic opioid.[1] It is a diastereoisomer of alphacetylmethadol (as well as levacetylmethadol).[1] In the United States, betacetylmethadol is a Schedule I drug under the Controlled Substances Act.[2]
See also
References
- ↑ 1.0 1.1 Newman JL, Vann RE, May EL, Beardsley PM (October 2002). "Heroin discriminative stimulus effects of methadone, LAAM and other isomers of acetylmethadol in rats". Psychopharmacology 164 (1): 108–14. doi:10.1007/s00213-002-1198-8. PMID 12373424.
- ↑
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||